Accessibility Menu
Ryman Healthcare logo

Ryman Healthcare

(OTC) RYHTY

Current Price$6.11
Market Cap$1.24B
Since IPO (2013)-65%
5 Year-86%
1 Year-17%
1 Month+0%

Ryman Healthcare Financials at a Glance

Market Cap

$1.24B

Revenue (TTM)

NZ$1.55B

Net Income (TTM)

-NZ$611.80M

EPS (TTM)

-$0.49

P/E Ratio

-12.39

Dividend

$0.00

Beta (Volatility)

0.20 (Low)

Price

$6.11

Volume

21

Open

$6.33

Previous Close

$6.11

Daily Range

$6.11 - $6.33

52-Week Range

$6.11 - $8.61

Estimated Earnings Date

May 26, 2026

RYHTY News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ryman Healthcare

Industry

Healthcare Providers and Services

Employees

7,800

CEO

Naomi James

Headquarters

Christchurch, 8042, NZ

RYHTY Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-2%

Net Income Margin

-21%

Return on Equity

-4%

Return on Capital

-0%

Return on Assets

-1%

Earnings Yield

-8.07%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.24B

Shares Outstanding

202.97M

Volume

21

Avg. Volume

19.172

Financials (TTM)

Gross Profit

-NZ$18.34M

Operating Income

-NZ$18.34M

EBITDA

NZ$25.59M

Operating Cash Flow

NZ$330.03M

Capital Expenditure

-NZ$48.83M

Free Cash Flow

NZ$281.20M

Cash & ST Invst.

NZ$9.73M

Total Debt

NZ$1.60B

Ryman Healthcare Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

NZ$418.73M

+14.4%

Gross Profit

-NZ$8.09M

-218.3%

Gross Margin

-1.93%

N/A

Market Cap

$1.24B

N/A

Market Cap/Employee

$161.06K

N/A

Employees

7,700

N/A

Net Income

-NZ$128.96M

+29.1%

EBITDA

NZ$13.11M

+105.1%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

NZ$9.73M

-81.3%

Total Debt

NZ$1.60B

-37.8%

Accounts Receivable

NZ$165.79M

-76.1%

Inventory

NZ$12.04K

-99.5%

Long Term Debt

NZ$1.45B

-43.7%

Short Term Debt

NZ$150.09M

N/A

Return on Assets

-1.40%

N/A

Return on Invested Capital

-0.15%

N/A

Free Cash Flow

NZ$126.48M

-47.5%

Operating Cash Flow

NZ$155.72M

-51.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GNTLFGenetic Technologies Limited
$1.00+0.00%
LWSCFSienna Senior Living Inc.
$15.46+0.58%
LTGHYLife Healthcare Group Holdings Limited
$2.46-2.38%
NPPNYNippon Shinyaku Co., Ltd.
$6.16+0.64%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$133.99+0.11%
NOKNokia
$13.49-0.02%
AALAmerican Airlines Group
$15.99+0.04%
PFEPfizer
$25.21-0.03%

Questions About RYHTY

What is the current price of Ryman Healthcare?

Ryman Healthcare is trading at $6.11 per share.

What is the 52-week range for Ryman Healthcare?

Over the past 52 weeks, Ryman Healthcare has traded between $6.11 and $8.61.

How much debt does Ryman Healthcare have?

As of the most recent reporting period, Ryman Healthcare reported total debt of NZ$908.10M.

How much cash does Ryman Healthcare have on hand?

Ryman Healthcare reported NZ$5.53M in cash and cash equivalents in its most recent financial results.

What is Ryman Healthcare’s dividend yield?

Ryman Healthcare does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.